Your browser doesn't support javascript.
loading
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes.
Del Giudice, Francesco; Kim, Wansuk; Li, Shufeng; DE Berardinis, Ettore; Sciarra, Alessandro; Salciccia, Stefano; Ferro, Matteo; Autorino, Riccardo; Pandolfo, Savio D; Crocetto, Felice; Galfano, Antonio; Dell'oglio, Paolo; Cacciamani, Giovanni E; Pradere, Benjamin; Laukhtina, Ekaterina; D'Andrea, David; Belladelli, Federico; Krajewski, Wojciech; Mari, Andrea; Minervini, Andrea; Gallioli, Andrea; Amparore, Daniele; Checcucci, Enrico; Fiori, Cristian; Porpiglia, Francesco; Morgantini, Luca; Crivellaro, Simone; Chung, Benjamin I.
Afiliação
  • Del Giudice F; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy - francesco.delgiudice@uniroma1.it.
  • Kim W; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA - francesco.delgiudice@uniroma1.it.
  • Li S; Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • DE Berardinis E; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
  • Sciarra A; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
  • Salciccia S; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.
  • Ferro M; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.
  • Autorino R; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.
  • Pandolfo SD; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  • Crocetto F; Division of Urology, VCU Health, Richmond, VA, USA.
  • Galfano A; Division of Urology, VCU Health, Richmond, VA, USA.
  • Dell'oglio P; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Cacciamani GE; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Pradere B; Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Laukhtina E; Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • D'Andrea D; USC Institute of Urology, University of Southern California, Los Angeles, CA, USA.
  • Belladelli F; Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France.
  • Krajewski W; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Mari A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Minervini A; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
  • Gallioli A; Division of Experimental Oncology, Unit of Urology, URI, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
  • Amparore D; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Medical University of Wroclaw, Wroclaw, Poland.
  • Checcucci E; Unit of Oncologic Minimally Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
  • Fiori C; Unit of Oncologic Minimally Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
  • Porpiglia F; Department of Urology, Puigvert Foundation, Barcelona, Spain.
  • Morgantini L; Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.
  • Crivellaro S; Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.
  • Chung BI; Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.
Minerva Urol Nephrol ; 75(1): 73-84, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36197701
ABSTRACT

BACKGROUND:

Incidentally diagnosed adrenal masses represent an entity that can result in either long term follow-up, surgical excision, or both. Understanding when and which adrenal masses are ultimately excised surgically is not well understood. We sought to understand the ultimate fate of these incidentalomas using a large population-based dataset.

METHODS:

The primary outcome of the study was determining the trend in adoption of surveillance vs. surgical excision according to socio-demographic, economic, and pathologic indices, and also provider specialty. Secondary outcomes were the assessment of perioperative complications, operative time, surgical approach, hospital stay, and provider specialty (general surgery vs. urology) among the cohort that underwent excision.

RESULTS:

Out of a total of N.=91,560 adrenal masses, ultimately N.=3375 (3.83%) of these underwent surgical excision. In the surgical excision cohort, the incidence of aldosteronoma, functional adenoma/Cushing's disease, and adrenocortical carcinoma was higher than in the surveillance cohort. Those patients who were older, female, and with higher Charlson Comorbidity indexes (CCI) were less likely to undergo surgical resection. Factors that predicted for an increased probability of resection included obtaining more CT/MRI scans as well as general surgeons as primary physician providers. Over the study period, the vast majority of surgeries were performed by surgeons other than urologists (12.9%) and open and laparoscopic approaches dominated, with the robotic-assisted approach accounting for a minority of the surgical cases (23.9%). The minimally invasive surgery (MIS) approach independently predicted for both lower rates of complications and shorter hospital stay.

CONCLUSIONS:

In the US, adrenal incidentalomas are more likely to undergo surveillance rather than surgical resection. In our study, surgery is mainly offered for functional or malignant disease and the receipt of surgery can vary by physician specialty. A MIS approach independently predicted for both lower rates of complications and shorter hospital stay.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Neoplasias das Glândulas Suprarrenais / Carcinoma Adrenocortical Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Minerva Urol Nephrol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Neoplasias das Glândulas Suprarrenais / Carcinoma Adrenocortical Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Minerva Urol Nephrol Ano de publicação: 2023 Tipo de documento: Article